vs
LGL GROUP INC（LGL）与Varex Imaging Corp（VREX）财务数据对比。点击上方公司名可切换其他公司
Varex Imaging Corp的季度营收约是LGL GROUP INC的261.0倍（$209.6M vs $803.0K）。Varex Imaging Corp净利率更高（1.1% vs -3.4%，领先4.5%）。LGL GROUP INC同比增速更快（23.0% vs 4.9%）。过去两年LGL GROUP INC的营收复合增速更高（43.1% vs 0.8%）
LGL集团是一家全球性电子元器件制造商，主营高性能频率控制产品、射频组件及集成电路解决方案的设计、生产与销售，核心服务航空航天、国防、通信、工业及医疗科技等对零部件可靠性要求较高的下游领域。
Varex Imaging是全球知名的影像组件及解决方案供应商，核心产品涵盖X射线管、数字平板探测器和图像处理软件，广泛应用于医疗诊断、放射肿瘤治疗及工业无损检测等领域，客户覆盖全球主要市场。
LGL vs VREX — 直观对比
营收规模更大
VREX
是对方的261.0倍
$803.0K
营收增速更快
LGL
高出18.1%
4.9%
净利率更高
VREX
高出4.5%
-3.4%
两年增速更快
LGL
近两年复合增速
0.8%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $803.0K | $209.6M |
| 净利润 | $-27.0K | $2.3M |
| 毛利率 | — | 33.3% |
| 营业利润率 | 14.8% | 7.3% |
| 净利率 | -3.4% | 1.1% |
| 营收同比 | 23.0% | 4.9% |
| 净利润同比 | -113.4% | 866.7% |
| 每股收益（稀释后） | $-0.02 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LGLVREX
| Q1 26 | — | $209.6M | ||
| Q4 25 | $803.0K | $228.9M | ||
| Q3 25 | $661.0K | $203.0M | ||
| Q2 25 | $491.0K | $212.9M | ||
| Q1 25 | $498.0K | $199.8M | ||
| Q4 24 | $653.0K | — | ||
| Q3 24 | $650.0K | $205.7M | ||
| Q2 24 | $531.0K | $209.1M |
净利润LGLVREX
| Q1 26 | — | $2.3M | ||
| Q4 25 | $-27.0K | $12.2M | ||
| Q3 25 | $772.0K | $-89.1M | ||
| Q2 25 | $-51.0K | $6.9M | ||
| Q1 25 | $-6.0K | $-300.0K | ||
| Q4 24 | $202.0K | — | ||
| Q3 24 | $72.0K | $-51.1M | ||
| Q2 24 | $137.0K | $1.4M |
毛利率LGLVREX
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
营业利润率LGLVREX
| Q1 26 | — | 7.3% | ||
| Q4 25 | 14.8% | 8.6% | ||
| Q3 25 | 18.2% | -39.8% | ||
| Q2 25 | -6.3% | 10.4% | ||
| Q1 25 | 8.2% | 5.6% | ||
| Q4 24 | 37.5% | — | ||
| Q3 24 | 21.2% | 5.3% | ||
| Q2 24 | 44.6% | 4.4% |
净利率LGLVREX
| Q1 26 | — | 1.1% | ||
| Q4 25 | -3.4% | 5.3% | ||
| Q3 25 | 116.8% | -43.9% | ||
| Q2 25 | -10.4% | 3.2% | ||
| Q1 25 | -1.2% | -0.2% | ||
| Q4 24 | 30.9% | — | ||
| Q3 24 | 11.1% | -24.8% | ||
| Q2 24 | 25.8% | 0.7% |
每股收益（稀释后）LGLVREX
| Q1 26 | — | $0.05 | ||
| Q4 25 | $-0.02 | $0.29 | ||
| Q3 25 | $0.14 | $-2.15 | ||
| Q2 25 | $-0.01 | $0.17 | ||
| Q1 25 | $0.00 | $-0.01 | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.01 | $-1.25 | ||
| Q2 24 | $0.02 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $41.5M | $125.6M |
| 总债务越低越好 | — | $367.6M |
| 股东权益账面价值 | $43.5M | $476.9M |
| 总资产 | $46.8M | $1.1B |
| 负债/权益比越低杠杆越低 | — | 0.77× |
8季度趋势，按日历期对齐
现金及短期投资LGLVREX
| Q1 26 | — | $125.6M | ||
| Q4 25 | $41.5M | $155.1M | ||
| Q3 25 | $41.6M | $152.6M | ||
| Q2 25 | $41.8M | $223.0M | ||
| Q1 25 | $41.9M | $212.6M | ||
| Q4 24 | $41.6M | — | ||
| Q3 24 | $41.6M | $200.5M | ||
| Q2 24 | $41.1M | $190.0M |
总债务LGLVREX
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
股东权益LGLVREX
| Q1 26 | — | $476.9M | ||
| Q4 25 | $43.5M | $472.6M | ||
| Q3 25 | $39.8M | $455.3M | ||
| Q2 25 | $39.1M | $549.7M | ||
| Q1 25 | $39.2M | $540.2M | ||
| Q4 24 | $39.2M | — | ||
| Q3 24 | $39.0M | $529.1M | ||
| Q2 24 | $38.9M | $581.2M |
总资产LGLVREX
| Q1 26 | — | $1.1B | ||
| Q4 25 | $46.8M | $1.1B | ||
| Q3 25 | $43.3M | $1.1B | ||
| Q2 25 | $43.0M | $1.4B | ||
| Q1 25 | $43.3M | $1.3B | ||
| Q4 24 | $43.1M | — | ||
| Q3 24 | $42.5M | $1.2B | ||
| Q2 24 | $42.2M | $1.3B |
负债/权益比LGLVREX
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-355.0K | $-16.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-26.8M |
| 自由现金流率自由现金流/营收 | — | -12.8% |
| 资本支出强度资本支出/营收 | — | 5.1% |
| 现金转化率经营现金流/净利润 | — | -7.00× |
| 过去12个月自由现金流最近4个季度 | — | $-13.3M |
8季度趋势，按日历期对齐
经营现金流LGLVREX
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $-355.0K | $7.9M | ||
| Q3 25 | $275.0K | $7.7M | ||
| Q2 25 | $-190.0K | $16.6M | ||
| Q1 25 | $340.0K | $9.5M | ||
| Q4 24 | $-17.0K | — | ||
| Q3 24 | $528.0K | $25.9M | ||
| Q2 24 | $203.0K | $8.0M |
自由现金流LGLVREX
| Q1 26 | — | $-26.8M | ||
| Q4 25 | — | $2.3M | ||
| Q3 25 | — | $1.4M | ||
| Q2 25 | — | $9.8M | ||
| Q1 25 | — | $5.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $19.9M | ||
| Q2 24 | — | $3.3M |
自由现金流率LGLVREX
| Q1 26 | — | -12.8% | ||
| Q4 25 | — | 1.0% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | 2.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | — | 1.6% |
资本支出强度LGLVREX
| Q1 26 | — | 5.1% | ||
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 3.1% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.9% | ||
| Q2 24 | — | 2.2% |
现金转化率LGLVREX
| Q1 26 | — | -7.00× | ||
| Q4 25 | — | 0.65× | ||
| Q3 25 | 0.36× | — | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.08× | — | ||
| Q3 24 | 7.33× | — | ||
| Q2 24 | 1.48× | 5.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LGL
暂无分部数据
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
